ArticleBMC cancer2022

Development and validation of MRI-based radiomics signatures as new markers for preoperative assessment of EGFR mutation and subtypes from bone metastases.

Ying Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.